Short and Intermediate Term Effect of Dapagliflozin on Left Ventricular Remodeling in Anterior STEMI Patients

PHASE3RecruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

April 15, 2022

Primary Completion Date

March 15, 2025

Study Completion Date

April 15, 2025

Conditions

STEMI

Interventions

DRUG

Dapagliflozin

Assess the efficacy of Dapagliflozin on cardiac function and LV remodeling in acute ST elevation anterior myocardial infarction patients

Trial Locations (1)

RECRUITING

Helwan University, Cairo

All Listed Sponsors

lead

Mohamed Nabil Elkholy

OTHER